CPESN® USA Announces New Agreement with Mobility Health

22 Sep 2022

CPESN® USA Announces New Agreement with Mobility Health

Success from CPESN® Ohio's network expands Mobility Heath relationship to include all 3,600 CPESN pharmacies across the country.

“We are thrilled to be able to expand our relationship with Mobility Health from our CPESN Ohio network to the rest of our local networks across the country," said Troy Trygstad, PharmD, MBA, PhD, Executive Director of CPESN USA.

CARY, N.C. (PRWEB) SEPTEMBER 14, 2022

CPESN USA, a clinically integrated, nationwide organization of pharmacy networks created to advance community-based pharmacy practice, has entered into an agreement with Mobility Health, a biohealth diagnostic company with a mission to transform community-based healthcare, to encourage its pharmacies to utilize lab testing services provided by the Mason, Ohio-based lab.

Mobility Health began working with the CPESN® Ohio network in November 2021. The success of the program has encouraged both companies to expand beyond Ohio and include all 3,600 CPESN pharmacies across the country.

“We are thrilled to be able to expand our relationship with Mobility Health from our CPESN Ohio network to the rest of our local networks across the country," said Troy Trygstad, PharmD, MBA, PhD, Executive Director of CPESN USA. “Mobility Health has been a collaborative and transparent partner – working together to figure out new ways to improve the care we provide to our patients.”

CPESN pharmacies collect COVID-19 / Flu A & B samples and send them directly to Mobility Health. Mobility Health covers overnight carrier fees and provides same or next day results to both the patient and the pharmacy. Mobility Health also helps ease the reporting burden placed on the pharmacies, which allows the pharmacy staff to focus on patient-care initiatives.

“Local, community-based pharmacies have long-standing and trusting relationships with their patients, and we want to be a resource to allow those relationships to flourish,” shared Scott Rueter, Director of Revenue Operations for Mobility Health. “We are excited to be able to expand our partnership with CPESN pharmacies across America and help them do what they do best, while also advancing our mission of providing advanced diagnostic services to all areas of the population, including those that are traditionally harder to reach, in the enduring fight against COVID-19 and other infectious diseases.”

For a list of pharmacies participating in the program, please visit: https://www.mobilityhealthlab.com/pharmacy-partners.

About CPESN® USA
CPESN® USA a clinically integrated, nationwide organization of pharmacy networks structured to advance community-based pharmacy practice. They empower community-based pharmacies that are deeply rooted within their community by fostering their ability to provide high quality, patient-centered enhanced services. CPESN® pharmacies integrate with other healthcare providers on the patient’s care team to coordinate medical treatment. The results are better medication adherence, higher patient satisfaction, and lower healthcare costs. You can find CPESN® Networks of pharmacy providers in 42 states across America. To learn more, please visit http://www.CPESN.com.

About Mobility Health
Mobility Health is a biohealth diagnostic company focused on providing accurate, rapid testing of infectious diseases to protect population health and safety. Mobility Health was established with a mission to transform community-based healthcare by deploying new technologies that eliminate barriers to rapid, advanced molecular testing and healthcare services. Founded in 2020 by Sandra Gunselman, Ph.D., a molecular biology and laboratory operations expert with a passion for reaching patients in need, the company combines cutting-edge laboratory technologies with mobile capabilities to offer unique services to underserved communities. For more information, visit http://www.mobilityhealthlab.com.